DUNCKER STREETT & CO INC - PROGENICS PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 131 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 1.40 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
DUNCKER STREETT & CO INC ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2020$25,000
-24.2%
6,5000.0%0.01%0.0%
Q4 2019$33,000
-28.3%
6,500
-13.3%
0.01%
-30.0%
Q2 2019$46,000
-22.0%
7,500
-40.6%
0.01%
-28.6%
Q1 2019$59,000
+11.3%
12,6180.0%0.01%0.0%
Q4 2018$53,000
-46.5%
12,618
-19.7%
0.01%
-36.4%
Q3 2018$99,000
-21.4%
15,7180.0%0.02%
-29.0%
Q2 2018$126,000
+7.7%
15,7180.0%0.03%
+3.3%
Q1 2018$117,000
+33.0%
15,718
+6.8%
0.03%
+30.4%
Q4 2017$88,000
-18.5%
14,7180.0%0.02%
-30.3%
Q3 2017$108,000
+8.0%
14,7180.0%0.03%
+6.5%
Q2 2017$100,000
-28.1%
14,7180.0%0.03%
-29.5%
Q1 2017$139,000
+9.4%
14,7180.0%0.04%
+4.8%
Q4 2016$127,000
+36.6%
14,7180.0%0.04%
+31.2%
Q3 2016$93,000
+31.0%
14,718
-12.0%
0.03%
+28.0%
Q2 2016$71,000
-2.7%
16,7180.0%0.02%
-7.4%
Q1 2016$73,000
-36.5%
16,718
-10.7%
0.03%
-37.2%
Q4 2015$115,000
-15.4%
18,718
-21.1%
0.04%
-18.9%
Q3 2015$136,000
-27.7%
23,718
-5.9%
0.05%
-19.7%
Q2 2015$188,000
+24.5%
25,2180.0%0.07%
+34.7%
Q1 2015$151,000
-20.9%
25,2180.0%0.05%
-22.2%
Q4 2014$191,000
+45.8%
25,2180.0%0.06%
+40.0%
Q3 2014$131,000
-4.4%
25,218
-20.5%
0.04%
+2.3%
Q2 2014$137,000
+37.0%
31,718
+29.3%
0.04%
+25.7%
Q1 2014$100,000
-23.7%
24,5250.0%0.04%
-25.5%
Q4 2013$131,000
+6.5%
24,5250.0%0.05%
-6.0%
Q3 2013$123,000
+12.8%
24,5250.0%0.05%
+19.0%
Q2 2013$109,000–24,525–0.04%–
 Download
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q4 2019.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders